Aurora Cannabis Inc. (NASDAQ:ACB) Sees Significant Growth in Short Interest

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a significant growth in short interest in November. As of November 15th, there was short interest totalling 4,380,000 shares, a growth of 55.9% from the October 31st total of 2,810,000 shares. Approximately 8.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 985,600 shares, the days-to-cover ratio is presently 4.4 days.

Aurora Cannabis Price Performance

Shares of ACB stock opened at $4.55 on Friday. The stock has a market capitalization of $249.52 million, a price-to-earnings ratio of -6.04 and a beta of 1.87. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a twelve month low of $2.84 and a twelve month high of $9.35. The stock has a fifty day simple moving average of $5.26 and a two-hundred day simple moving average of $5.73.

Hedge Funds Weigh In On Aurora Cannabis

Several institutional investors and hedge funds have recently modified their holdings of ACB. Cetera Advisors LLC acquired a new position in shares of Aurora Cannabis during the 1st quarter valued at about $59,000. Virtu Financial LLC purchased a new stake in shares of Aurora Cannabis in the 1st quarter valued at approximately $727,000. Headlands Technologies LLC raised its holdings in shares of Aurora Cannabis by 98.8% in the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after purchasing an additional 37,269 shares in the last quarter. TD Asset Management Inc acquired a new position in shares of Aurora Cannabis during the second quarter worth $255,000. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of Aurora Cannabis in the 2nd quarter valued at about $50,000. Institutional investors and hedge funds own 47.63% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.